cured but the epithelial defect persisted. To provide a therapeutic ptosis botulinum toxin was injected into the upper lid. Subsequently the epithelium healed and there has been no recurrence of the defect to date. There is however a residual central stromal scar. Comment 5-FU is an antimetabolite which interferes with normal cell mitosis. It interfers with the S phase and the G2 phase of the cell cycle which correspond, respectively, with the synthesis of DNA and cellular components required for mitosis.' As corneal epithelial cells are constantly undergoing replication they are particularly susceptible to its toxic effects.
Reduction of dosage has been suggested as a method of reducing complications including potential toxicity to corneal epithelium. (Fig 4) . The scleral abscess in the left eye improved without surgical intervention. Visual acuity is perception oflight in the right eye due to a dense lens opacity and 6/5 in the left. The anterior sclera is more susceptible to the effect of radiotherapy than posterior sclera.' We see late complications from doses as low as 1800-2000 cGy. Our experience is similar to other authors4 who report that the risk of endophthalmitis is greatest with severe scleral thinning but scleromalacia is not significantly correlated to dose ofradiation. With the risk ofscleral necrosis of 4 5%4 and a lifelong risk of endophthalnitis following radiotherapy we no longer recommend this treatment. We remove more than 100 pterygia per year in our institution and conjunctival autografting is our treatment of choice to reduce recurrences. 
